Endocrinology Flashcards
what is the step wise management of obesity
conservative: diet & exercise
medical
surgical
what is orlistat & its side effects
pancreatic lipase inhibitor used in the medical treatment of obesity
loose stool/diarrhoea
flatulence
faecal urgency/incontinence
what is the criteria for orlistat to be prescribed
BMI of 28 kg/m^2 or more with associated risk factors, or
BMI of 30 kg/m^2 or more
continued weight loss e.g. 5% at 3 months
orlistat is normally used for < 1 year
contraindications for orlistat
critical medications e.g. COCP, anti-epileptics
increased transit time through the gut caused by orlistat could reduce absorption & efficacy of vital medications
what should patients on long term steroids do to their dose when have a concurrent illness?
double hydrocortisone dose
side effects of glucocorticoids
endocrine: impaired glucose regulation, increased appetite/weight gain, hirsutism
cushing’s syndrome
MSK: osteoporosis, proximal myopathy, avascular necrosis of femoral head
immunosuppression: TB reactivation
psychiatric: insomnia, mania, depression, psychosis
GI: peptic ulceration, pancreatitis
ophthalmic: glaucoma, cataracts
suppression of growth in children
intracranial hypertension
neutrophilia
side effects of mineralocorticoids
hypertension
fluid retention
what is an Addisonian crisis/adrenal crisis
an acute presentation of severe Addison’s, where the absence of steroids leads to a life threatening presentation
can be first presentation of Addison’s
triggered by trauma, infection, or other acute illness
can happen if someone stops steroids abruptly
presentation of adrenal crisis
hypotension
hyponatremia, hyperkalaemia
hypoglycaemia
reduced consciousness
patients can be very unwell
management of adrenal crisis
Intensive monitoring if unwell
Parenteral steroids (i.e. IV hydrocortisone 100mg stat then 100mg every 6 hours)
IV fluid resuscitation
Correct hypoglycaemia
Careful monitoring of electrolytes and fluid balance
unique features of Grave’s disease
exophthalmos
ophthalmoplegia
pretibial myxoedema
thyroid acropachy:
clubbing
soft tissue swelling of hands and feet
periosteal new bone formation
** all due to TSH receptor antibodies
what is pretibial myxoedema
dermatological condition
deposits of mucin under the skin of the anterior aspect of the leg
gives a discoloured, waxy, oedematous appearance to the skin over the area
pathophysiology of hyperaldosteronism
in the afferent arterioles of the kidneys there are juxtaglomerular cells which detect BP in the vessels
if low, they secrete renin
Liver in turn release a protein called angiotensinogen, which renin converts to angiotensin I
Angiotensin I –> 2 in the lungs by ACE
Angiotensin II stimulates release of aldosterone from the adrenal glands
results in:
Increase sodium reabsorption from the distal tubule
Increase potassium secretion from the distal tubule
Increase hydrogen secretion from the collecting ducts
what type of steroid is aldosterone
mineralocorticoid
features of primary hyperaldosteronism
hypertension
hypokalemia
***muscle weakness
alkalosis
causes of primary hyperaldosteronism
adrenal glands producing too much aldosterone, resulting in low renin
bilateral adrenal hyperplasia**
adrenal adenoma
Familial hyperaldosteronism type 1 and type 2
causes of secondary hyperaldosteronism
excessive renin being produced which simultaneously produces more aldosterone
occurs when BP in the kidneys is proportionately lower to the BP in the rest of the body
renal artery stenosis
renal artery obstruction
HF
investigations for hyperaldosteronism
aldosterone/renin ratio
BP, U&Es, blood gas
Then:
high resolution CT abdomen** / MRI to look for an adrenal tumour
Renal doppler ultrasound, CT angiogram or MRA for renal artery stenosis or obstruction
management of hyperaldosteronism
adenoma:surgery
hyperplasia: aldosterone antagonists e.g. spironolactone, Eplerenone
percutaneous renal artery angioplasty via the femoral artery to treat in renal artery stenosis
drug causes of gynaecomastia
spironolactone***
cimetidine
digoxin
cannabis
finasteride
GnRH agonists e.g. goserelin, buserelin
oestrogens, anabolic steroids
pathophysiology of androgen insensitivity syndrome
x linked recessive condition
cells unable to respond to androgens due to a lack of receptor
Patients are genetically male with XY sex chromosome
However, due to no response to testosterone & excess androgens being converted to estrogen = female phenotype externally
testes in the abdomen or inguinal canal, and absence of a uterus, upper vagina, cervix, fallopian tubes and ovaries. The female internal organs do not develop because the testes produce anti-Müllerian hormone, which prevents males from developing an upper vagina, uterus, cervix and fallopian tubes
insensitivity to androgens also results in a lack of pubic hair, facial hair and male type muscle development. Patients tend to be slightly taller than the female average.
presentation of androgen insensitivity syndrome
often presents in infancy with inguinal hernias containing testes
or at puberty with primary amennorhoea
Raised LH
Normal or raised FSH
Normal or raised testosterone levels (for a male)
Raised oestrogen levels (for a male)
what is there an increased risk of in androgen insensitivity syndrome
testicular cancer
requires a bilateral orchidectomy
management of androgen insensitivity syndrome
Bilateral orchidectomy (removal of the testes) to avoid testicular tumours
Oestrogen therapy
Vaginal dilators or vaginal surgery can be used to create an adequate vaginal length
side effects of SGLT2-I
urinary & genital infections
normoglycaemic ketoacidosis
increased risk of lower limb amputation
** patients often lose weight which can be beneficial in T2DM
how to monitor & adapt levothyroxine dose in pregnancy
increase dose by up to 50% as early as 4-6 weeks
serum TSH measured in each trimester and 6-8 weeks post partum
what is transient gestational hyperthyroidism
activation of the TSH receptor by HCG may also occur
HCG levels will fall in the second and third trimester
management of hyperthyroidism in pregnancy
propylthiouracil in the 1st trimester (carbimazole associated with congenital abnormalities)
at the start of the 2nd trimester, should be transferred back to carbimazole
maternal free thyroxine levels should be kept in the upper third of the normal reference range to avoid fetal hypothyroidism
thyrotrophin receptor stimulating antibodies should be checked at 30-36 weeks gestation - helps to determine the risk of neonatal thyroid problems
features of subclinical hypothyroidism
TSH raised but T3, T4 normal
no obvious symptoms
management of subclinical hypothyroidism
if TSH 4-10
if <65yrs and have symptoms, trial levothyroxine
>80 yrs, watch and wait
if no symptoms, repeat TFTs in 6 months
TSH >10
<70yrs start treatment even if asymptomatic
in older people follow a watch & wait approach
should patients with T2DM be offered a statin?
only if QRISK >10%
then start atorvastatin 20mg
BP targets for those with T2DM
same as those without T2DM
<80 yrs
clinic: 140/90
home: 135/85
> 80 yrs
clinic: 150/90
home: 145/85
MOA of DPP-4 inhibitors
prevent the breakdown of incretins
**hormones produced by the GI tract in response to large meals, reducing the blood sugar levels
Increase insulin secretions
Inhibit glucagon production
Slow absorption by the GI tract
side effects of DPP-4 inhibitors
GI tract upset
Symptoms of upper respiratory tract infection
Pancreatitis
what is the range for impaired fasting glucose
6.1-6.9mmol/L
what is the range for impaired glucose tolerance
plasma glucose at 2 hours 7.8 – 11.1 mmol/l on an OGTT